Seeking Alpha

Shire PLC (SHPG)

  • Chris DeMuth Jr. | Send Message 4 Feb

    Congratulations Covidien: You Escaped In Time $WBA, $SHPG, $ABBV
      • Mike Zaman | Send Message 31 Jan

        Shire Plc (SHPG) Binge Eating Treatment FDA-Approved, Chimerix (CMRX) Stops Ebola Drug Studies $CMRX, $SHPG
          • Clinically Sound Investor | Send Message 23 Jan

            The 2015 Calendar Of NASH Trial Catalysts: Shire And Immuron $SHPG
              • Chronic Bull | Send Message 17 Jan

                Shire PLC : Potential Synergies From Acquisition $SHPG
                  • DAG Investments | Send Message 11 Jan

                    $SHPG "Shire to Buy NPS Pharmaceuticals for $5.2 Billion"
                      • Balanced Investor | Send Message 17 Dec 2014

                        $NPSP may be takeover target for $SHPG; Benzinga confirmed filed 8-K shows multi billion $ loan after failed bid for $MRK
                        Reply (1)
                        • ksualum98 | Send Message 12 Jan
                          : Good call!
                          • VogelHood Research | Send Message 28 Oct 2014

                            Why The AbbVie/Shire Deal Collapsed $ABBV, $SHPG
                              • Clinically Sound Investor | Send Message 27 Oct 2014

                                Protalix Should Rise On Pivotal Near-Term Clinical Trial Catalyst And Longer-Term... $ALIOF, $PFE, $SHPG
                                  • PEMINC | Send Message 16 Oct 2014

                                    How much of this $GILD price action is contagion selling precipitated by margin calls on risk arbs from the Shire ($SHPG) deal tanking?
                                      • Junius | Send Message 16 Oct 2014

                                        Shire likely to get a $1.64 billion break-up fee $SHPG $ABBV
                                          Visit Seeking Alpha's
                                          SHPG vs. ETF Alternatives
                                          Company Description
                                          Shire PLC is a specialty biopharmaceutical company that focuses on developing and marketingspecialty medicines that address unmet patient needs.